Related references
Note: Only part of the references are listed.Brexanolone iv efficacy in postpartum depression in three pivotal trials: montgomery-asberg depression rating scale assessment
Christine Clemson et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
Evaluation of breast milk concentrations following brexanolone iv administration to healthy lactating women
Ethan Hoffmann et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2019)
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer-Brody et al.
LANCET (2018)
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression
Stephen J. Kanes et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2017)
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
Stephen Kanes et al.
LANCET (2017)
Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depression
Samet Kose et al.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY (2017)
The role of reproductive hormones in postpartum depression
Crystal Edler Schiller et al.
CNS SPECTRUMS (2015)
Allopregnanolone as a mediator of affective switching in reproductive mood disorders
Crystal Edler Schiller et al.
PSYCHOPHARMACOLOGY (2014)
Neurosteroids, stress and depression: Potential therapeutic opportunities
Charles F. Zorumski et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
When Depression Complicates Childbearing: Guidelines for Screening and Treatment During Antenatal and Postpartum Obstetric Care
Maria Muzik et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2009)
Share Paper
